Transient response of cardiac angiosarcoma to paclitaxel

European Journal of Cancer Care

Volumn 19, Issue 5, 2010, Pages 699-700

  Castilla, E ^a   Pascual, I ^a   Roncales F ^a   Aguirre, E ^a   Del Rio A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Angiosarcoma; Cardiac malignancy; Diagnosis; Management; Paclitaxel

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ADULT; ANGIOSARCOMA; ARTICLE; CASE REPORT; FATALITY; HEART TUMOR; HUMAN; MALE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FATAL OUTCOME; HEART NEOPLASMS; HEMANGIOSARCOMA; HUMANS; MALE; PACLITAXEL; TREATMENT OUTCOME;

EID: 77955760424     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01084.x     Document Type: Article

References (4)

1. Baay P, Karwande SV, Kushner JP, Olsen S, Renlund DG. Successful treatment of cardiac angiosarcoma with combined modality therapy. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation 1994, 13:923-925.
2. Burke A, Jeudy J, Virmani R. Cardiac tumours: an update. Heart 2008, 94:117-123.
3. Good AB, Nascimento A, Welker KM, Arndt CA. Congenital angiosarcoma with transient response to paclitaxel. Journal of Pediatric Hematology/Oncology: Official Journal of the American Society of Pediatric Hematology/Oncology 2008, 30:451-453.
4. Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clinical Oncology [Royal College of Radiologists (Great Britain)] 2007, 19:748-756.